Ressources

Les ressources sont temporairement présentées en anglais

• Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine.
  Canadian Immunization Committee .
  Public Health Agency of Canada; 2010
  Contains information about the epidemiology of meningococcal disease and the recommended use of vaccines to protect against infection.
• Canada Communicable Disease Report. (PDF)
  - Canada Communicable Disease Report 2009;35(ACS3).
  National Advisory Committee on Immunization (NACI) - April 2009 update on the Invasive Meningococcal Disease and Meningococcal Vaccine Conjugate Recommendations
• Canadian immunization guide. (PDF: 4.4m) 7th ed.
  National Advisory Committee on Immunization
  Public Health Agency of Canada; 2006
  Presents information on the immunizing agents available in Canada and their use in the prevention of communicable diseases. Discusses recommendations on routine immunizations and answers queries from providers regarding immunization.
• Getting your shots (CPS).
  Canadian Paediatric Society; 2003
  Offers information on vaccines in Canada, written in plain language. Includes pamphlets on 5-in-1, measles, mumps and rubella, Diphtheria-tetanus-acellular pertussis, hepatitis B, chickenpox, pneumococcal vaccine, and meningococcal vaccine.
• Immunize your kids! (CCIAP). (PDF: 100k)
  Canadian Coalition for Immunization Awareness & Promotion; 2009
  Describes how immunization works and lists recommended vaccinations for children. For best results print this brochure on letter-sized paper. (Choose File > Page Setup; under Orientation pick Landscape, and in the drop-down menu, under Paper pick Letter. Click OK and then print as usual.
• It’s your health : Meningococcal vaccine (Health Canada). (PDF: 66k)
  Health Canada
  Gives information about meningococcal disease and how to minimize the risk of infection by getting vaccinated.
• Meningitis Research Foundation of Canada.
  Meningitis Research Foundation of Canada
  Ddicated to the prevention of meningitis, to improving survival rates and outcomes, and to the support of families of those whose lives have been changed by this disease.
• Meningococcal meningitis (WHO).
  World Health Organization; 2003
  Discusses meningococcal meningitis, including transmission, diagnosis, treatment, epidemiology, prevention and vaccination.
• Meningococcal Serogroup C Conjugate Vaccination in Canada: How Far Have We Progressed? How Far Do We Have to Go? (PDF: 127k)
  White Scott.
  - Canadian Journal of Public Health 2010;101(1):12-14.
  Canadian Public Health Association
  Since routine meningococcal C conjugate vaccination was introduced into Canada in 2002, there have been a large regional variation in the routine programs, changes to the timing of the infant series in some provinces, and wide differences in catch-up programs. As immunization is viewed as a provincial responsibility, less attention has been paid to determining national coverage rates and the direct and indirect effects of the widely varying provincial/territorial vaccination programs on the nation as a whole. Canada’s disjointed regional immunization campaigns leave the population at risk of disease for an extended length of time. The United Kingdom has proven that with a pro-active approach to planning, coordination, and implementation of a national immunization program, excellent long-term control of invasive meningococcal disease in a large population could be achieved in as little as one year. A summation of the current meningococcal immunization strategies used in Canada and an estimate of overall vaccine coverage of children and youth is provided.
• Meningococcal vaccine for children and adolescents (CPS). (PDF: 103k)
  Infectious Diseases and Immunization Committee, Canadian Paediatric Society
  - Paediatrics & Child Health 2005;10(7):405-6.
  Pulsus
  Offers the Canadian Pediatric Society’s position on vaccinations for meningococcal disease. Includes information about clinical presentations and epidemiology and vaccine development. Offers a summary and recommendations.
• NACI Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. (PDF: 748k)
  National Advisory Committee on Immunization
  - Canada Communicable Disease Report 2007;23(ACS-3):17520774.
  Public Health Agency of Canada
  » PubMed: 1-23
  Makes recommendations about the use of Menactra, a vaccine that provides protection against meningococcal serogroups A, C, Y and W135.
• Public Service Announcement (PSA) - Meningitis Research Foundation of Canada Feb 2008. (WMV: 3.0m); 2008
• Publications : immunization (ON).
  Ministry of Health and Long-Term Care
  Provides links to fact sheets on immunization.
• Unprotected people reports.
  Immunization Action Coalition
  Includes case reports, personal testimonies, newspaper and journal articles about people who have suffered or died from vaccine-preventable diseases.
• Update on the Invasive Meningococcal Disease and Meningococcal Vaccine Conjugate Recommendations.
  National Advisory Committee on Immunization; 2009
  Provides an update with regard to meningococcal disease and the currently available quadrivalent conjugate meningococcal vaccine, Menactra® (sanofi pasteur) and makes additional recommendations for the use of meningococcal conjugate vaccines.
• Your story (MRFC).
  Meningitis Research Foundation of Canada
  Forum where the public can post stories about their experience related to meningitis.